13D Filing: Longwood Fund II, L.P. and Kalvista Pharmaceuticals Inc. (KALV)

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

The Issuer has entered into an indemnification agreement with each of its directors and executive officers, including Aldrich. The indemnification agreement,
among other things, require the Issuer or will require the Issuer to indemnify Aldrich (and in certain cases LFII) to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys fees, judgments, fines
and settlement amounts incurred by Aldrich in any action or proceeding, including any action or proceeding by or in right of the Issuer, arising out of his services as a director. The form of Indemnification Agreement for the Issuers directors
and officers is attached as Exhibit 10.5 to the Issuers Registration Statement on Form S-1 (File No. 333-211818), and is incorporated herein by reference.

Item 7. Material to be Filed as Exhibits.

Exhibit A
– Joint Filing Agreement

Exhibit B – Form of Director and Officer Indemnification Agreement, filed on June 3, 2016 as Exhibit 10.12 to the
Issuers Registration Statement on Form S-1 (File No. 333-211818), and incorporated herein by reference.